Rainer König

Alumni

Publications

Schacht T, Oswald M, Eils R, Eichmüller SB, König R (2014) Estimating the activity of transcription factors by the effect on their target genes. Bioinformatics 30(17), i401-i407.
Sonntag J, Bender C, Soons Z, Aulmann S, von der Heyde S, Nietert M, Lier A, König R, Wiemann S, Beißbarth T, Sinn HP, Schneeweiss A, Korf U (2014) Reverse phase protein array based tumor profiling identifies a biomarker signature for risk classification of hormone receptor-positive breast cancer Trans Proteomics 2, 52-59.
Suratanee A, Schaefer MH, Betts MJ, Soons Z, Mannsperger H, Harder N, Oswald M, Gipp M, Ramminger E, Marcus G, Männer R, Rohr K, Wanker E, Russell RB, Andrade-Navarro MA, Eils R, König R (2014) Characterizing Protein Interactions Employing a Genome-Wide siRNA Cellular Phenotyping Screen. PLOS Comput Biol 10(9), e1003814.
Ummanni R, Mannsperger HA, Sonntag J, Oswald M, Sharma AK, König R, Korf U (2014) Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery. Biochim Biophys Acta 1844(5), 950-959.
Ward A, Shukla K, Balwierz A, Soons Z, König R, Sahin O, Wiemann S (2014) MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer. J Pathol 233(4), 368-379.
Aschoff M, Hotz-Wagenblatt A, Glatting KH, Fischer M, Eils R, König R (2013) SplicingCompass: differential splicing detection using RNA-seq data. Bioinformatics 29(9), 1141-1148.
Gogolin S, Batra R, Harder N, Ehemann V, Paffhausen T, Diessl N, Sagulenko V, Benner A, Gade S, Nolte I, Rohr K, König R, Westermann F (2013) MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cells. Cancer Lett 331(1), 35-45.
Piro RM, Molineris I, Di Cunto F, Eils R, König R (2013) Disease-gene discovery by integration of 3D gene expression and transcription factor binding affinities. Bioinformatics 29(4), 468-475.
Plaimas K, Wang Y, Rotimi SO, Olasehinde G, Fatumo S, Lanzer M, Adebiyi E, König R (2013) Computational and experimental analysis identified 6-diazo-5-oxonorleucine as a potential agent for treating infection by Plasmodium falciparum. Infect Genet Evol 20, 389-395.
Reuss DE, Piro RM, Jones DT, Simon M, Ketter R, Kool M, Becker A, Sahm F, Pusch S, Meyer J, Hagenlocher C, Schweizer L, Capper D, Kickingereder P, Mucha J, Koelsche C, Jäger N, Santarius T, Tarpey PS, Stephens PJ, Andrew Futreal P, Wellenreuther R, Kraus J, Lenartz D, Herold-Mende C, Hartmann C, Mawrin C, Giese N, Eils R, Collins VP, König R, Wiestler OD, Pfister SM, von Deimling A (2013) Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta Neuropathol 125(3), 351-358.